Search research articles
Contact Us
Filters
Showing results (61-70 of 448) with videos related to
Page
of 45
Sort By:
Urologic Oncology
|
January 28, 2026
Molecular pathology of rare histologic variants and treatment-resistant lineages of prostate cancer
Ryuta Watanabe, Noriyoshi Miura, Tadahiko Kikugawa, et al.
Clinical Genitourinary Cancer
|
July 13, 2017
Prostate Cancer Screening in a New Era of Genetics
Heather H Cheng, Colin C Pritchard, Bruce Montgomery, et al.
JCO Precision Oncology
|
September 11, 2020
Polyclonal <i>BRCA2</i> Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate Cancer
Heather H Cheng, Stephen J Salipante, Peter S Nelson, et al.
Endocrine-Related Cancer
|
April 1, 2021
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches
Mark P Labrecque, Joshi J Alumkal, Ilsa M Coleman, et al.
Journal of the National Cancer Institute
|
November 7, 2002
Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition
Michael J Bonham, Anna Galkin, Bruce Montgomery, et al.
Hormones & Cancer
|
July 16, 2011
Testosterone regulates tight junction proteins and influences prostatic autoimmune responses
Jing Meng, Elahe A Mostaghel, Funda Vakar-Lopez, et al.
Rapid Communications in Mass Spectrometry : RCM
|
September 4, 2007
Analysis of testosterone and dihydrotestosterone from biological fluids as the oxime derivatives using high-performance liquid chromatography/tandem mass spectrometry
Thomas F Kalhorn, Stephanie T Page, William N Howald, et al.
Cancer Discovery
|
April 12, 2020
<i>TMPRSS2</i> and COVID-19: Serendipity or Opportunity for Intervention?
Konrad H Stopsack, Lorelei A Mucci, Emmanuel S Antonarakis, et al.
Cancer
|
July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer
R Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
The Journal of Biological Chemistry
|
January 7, 2005
Delayed dark adaptation in 11-cis-retinol dehydrogenase-deficient mice: a role of RDH11 in visual processes in vivo
Tom S Kim, Akiko Maeda, Tadao Maeda, et al.
Page
of 45
Search research articles
Search
Showing results (61-70 of 448) with videos related to
Sort By:
Page
of 45
Urologic Oncology
|
January 28, 2026
Molecular pathology of rare histologic variants and treatment-resistant lineages of prostate cancer
Ryuta Watanabe, Noriyoshi Miura, Tadahiko Kikugawa, et al.
Clinical Genitourinary Cancer
|
July 13, 2017
Prostate Cancer Screening in a New Era of Genetics
Heather H Cheng, Colin C Pritchard, Bruce Montgomery, et al.
JCO Precision Oncology
|
September 11, 2020
Polyclonal <i>BRCA2</i> Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate Cancer
Heather H Cheng, Stephen J Salipante, Peter S Nelson, et al.
Endocrine-Related Cancer
|
April 1, 2021
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches
Mark P Labrecque, Joshi J Alumkal, Ilsa M Coleman, et al.
Journal of the National Cancer Institute
|
November 7, 2002
Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition
Michael J Bonham, Anna Galkin, Bruce Montgomery, et al.
Hormones & Cancer
|
July 16, 2011
Testosterone regulates tight junction proteins and influences prostatic autoimmune responses
Jing Meng, Elahe A Mostaghel, Funda Vakar-Lopez, et al.
Rapid Communications in Mass Spectrometry : RCM
|
September 4, 2007
Analysis of testosterone and dihydrotestosterone from biological fluids as the oxime derivatives using high-performance liquid chromatography/tandem mass spectrometry
Thomas F Kalhorn, Stephanie T Page, William N Howald, et al.
Cancer Discovery
|
April 12, 2020
<i>TMPRSS2</i> and COVID-19: Serendipity or Opportunity for Intervention?
Konrad H Stopsack, Lorelei A Mucci, Emmanuel S Antonarakis, et al.
Cancer
|
July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer
R Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
The Journal of Biological Chemistry
|
January 7, 2005
Delayed dark adaptation in 11-cis-retinol dehydrogenase-deficient mice: a role of RDH11 in visual processes in vivo
Tom S Kim, Akiko Maeda, Tadao Maeda, et al.
Page
of 45